Predictors of Non-Adherence to Follow-up Visits and Deferasirox Chelation Therapy Among Jordanian Adolescents with Thalassemia Major-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of Non-Adherence to Follow-up Visits and Deferasirox Chelation Therapy Among Jordanian Adolescents with Thalassemia Major

Published:2014-08-12 Issue:7 Volume:31 Page:624-637
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Al-Kloub Manal Ibrahim,A bed Mona A.,Al khawaldeh Omar A.,Al Tawarah Yasin M.,Froelicher Erika Sivarajan

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.3109/08880018.2014.939792

Reference51 articles.

1. Deferasirox: Oral, once daily iron chelator — an expert opinion

2. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

3. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

4. World Health Organization (WHO). Adherence to long-term therapies evidence for action. Geneva: WHO Library Cataloguing-in-Publication Data; 2003.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deferasirox adherence in patients with thalassemia: Exploring the association with patient knowledge and ferritin levels;Pharmacia;2024-07-30

2. Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia;Pediatric Hematology and Oncology;2024-02-29

3. The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review;Health and Quality of Life Outcomes;2024-02-02

4. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia;Cochrane Database of Systematic Reviews;2023-03-06

5. Assessment of Iron Chelation Therapy Adherence in Patients with Thalassemia Major in Babylon Province;Journal of Applied Hematology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3